Abstract
Genetic polymorphism of the drug metabolism pathways is commonly encountered both for man and laboratory animal species. It is a major source of variable metabolism and linked events such as response to drugs and toxic substances. In man the cytochrome P-450 isozyme system exhibits considerable polymorphism. Several independent genetic polymorphisms regulating metabolic oxidation at C-, N-, and S-centres have been recently characterised. This phenomenon appears to be a powerful factor in determining biochemical individuality with respect to the oxidative metabolism of drugs and responsiveness to therapeutic agents. Of considerable importance is the recognition of the existence of phenotypes within the individual polymorphism, characterised by an impaired ability to effect metabolic oxidation. Evidence suggests that this factor can determine an increased susceptibility to experience exaggerated pharmacological effects and adverse reactions to several drugs.
Laboratory animal species also exhibit polymorphism with respect to several drug metabolic pathways but compared with man, this has been less extensively researched. The study of intra-species differences in metabolism of drugs and toxic substances can be of value:
-
(i)
when it occurs it may signal its possible occurrence in man and
-
(ii)
animal strain models of the human metabolic polymorphisms facilitate the laboratory study of inherited susceptibility to toxicants.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Al-Dabbagh SG, Idle JR, Smith RL (1981) Animal modelling of human polymorphic drug oxidation — the metabolism of debrisoquine and phenacetin in rat inbred strains. J Pharm Pharmac 33: 161–164
Arias IM, Gartner LM, Cohen M, Ben-Ezzer J, Levi AJ (1969) Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacological and genetic evidence for heterogeneity. Am J Med 47: 395–409
Boberg EW, Miller EC, Miller JA, Poland A, Liem A (1983) Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1’-hydroxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1’-hydroxysafrole in mouse liver. Cancer Res 43: 5163–5173
Bolton W, Carter TC, Morley Jones R (1976) The hen’s egg: genetics of taints in eggs from hens fed on rapeseed meal. Br Poult Sci 17: 313–320
Brewster MA, Schedewie H (1983) Trimethylaminuria. Annal Clin Lab Sci 13: 20–23
Cavalli-Sforza LL, Bodmer WF (1971) In: The Genetics of Human Populations. WH Freeman & Co, San Francisco
Devonshire HW, Kong I, Cooper M, Sloan TP, Idle JR, Smith RL (1983) The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition. Br J Clin Pharmacol 16: 157–166
Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ (1979) Defective N-oxidation of sparteine in man: A new pharmacogenetic defect. Eur J Clin Pharmacol 16: 183–187
Emery P, Panayi GS, Huston G, Welsh KI, Mitchell SC, Shah RR, Idle JR, Smith RL (1984) n-Penicillamine induced toxicity in rheumatoid arthritis: The role of sulphoxidation status and HLA-DR3. J Rheumatol 11: 626–632
Ford EB (1940) Polymorphism and taxonomy. In: Huxley J (ed) The New Systematics. Clarendon Press, Oxford, pp 493–573
Ford EB (1945) Polymorphism. Biol Rev 20: 73–88
Frymoyer JW, Jacox RF (1963) Investigation of the genetic control of sulfadiazine and isoniazid metabolism in the rabbit. J Lab Clin Med 62: 891–904
Geldmacher V, Mallinckrodt M, Lindorf HH, Petenyi M, Flugel M, Fischer T, Hiller T (1973) Genetisch determinierter polymorphismus der menschlichen serum-paraoxonase (EC 3.1.1.2). Humangenetik 17: 331–335
Haley CS, Waring RH, Mitchell SC, Shah RR, Idle JR, Smith RL (1985) Lack of congruence of Scarboxymethyl-L-cysteine sulphoxidation and debrisoquine in a Caucasian population. Xenobiotica 15: 445–450
Idle JR, Smith RL (1984) The debrisoquine hydroxylation gene: a gene of multiple consequence. Proc Second World Conference on Clinical Pharmacology and Therapeutics, Washington DC, pp 148–164
Kleinbloesem CH, Brummelen P van, Faber H, Danhof M, Vermeulen NPE, Breimer DD (1984) Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man. Biochem Pharmacol 33: 3721–3724
Kong I, Devonshire HW, Cooper M, Sloan TP, Idle JR, Smith RL (1982) The influence of oxidation phenotype on phenacetin metabolism and haemotoxicity. Brit J Clin Pharmacol 13:275–276
Lyman SD, Poland A (1983) Effect of the brachymorphic trait in mice on xenobiotic sulphate ester formation. Biochem Pharmacol 32: 3345–3350
Mahgoub A, Dring LG, Idle JR, Lancaster R, Smith RL (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet 2: 584–587
Mitchell SC, Waring RH, Haley CS, Idle JR, Smith RL (1984) Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. Br J Clin Pharmac 18:507–521
Morgan MY, Reshef R, Shah RR, Oates NS, Smith RL, Sherlock S (1984) Impaired oxidation of debrisoquine in patients with perhexiline liver injury. Gut 25: 1057–1064
Oates NS, Shah RR, Idle JR, Smith RL (1984) The metabolic disposition of the stereoisomers of perhexiline maleate and the influence of oxidation phenotype. Brit J Clin Pharmacol 18: 307
Oesch F, Zimmer A, Glaff HR (1983) Microsomal epoxide hydrolase in different rat strains. Biochem Pharmacol 32: 1783–1788
Penno MB, Vesell ES (1983) Monogenic control of variations in antipyrine metabolite formation. J Clin Invest 71: 1698–1709
Popper H (1985) In: Matern S, Bock KW, Gerok W (eds) Advances in glucuronide conjugation. Falk Symposium 40, MTP Press, USA, p 376
Portman OW, Alexander M, Cornelius CE, Chowdhury JR, Chowdhury NR, Arias IM (1984) The effects of nutrition on unconjugated plasma bilirubin concentration in squirrel monkeys. Hepatology 4: 454–460
Price-Evans DAP, White TA (1964) Human acetylation polymorphism. J Lab Clin Med 63:394
Roden DM, Reete SB, Higgins SB, Mayol RF, Gammans RE, Oates JA, Woosley RL (1980) Total suppression of ventricular arrhythmias by encainide. N Engl J Med 302: 877–882
Scott J, Poffenbarger PL (1979) Pharmacogenetics of tolbutamide metabolism in human Diabetes 28: 41–51
Shah RR, Oates NS, Idle JR, Smith RL (1982) Impaired debrisoquine hydroxylation with perhexiline induced neuropathy. Brit Med J 295–299
Smith RL (1985) Genetic polymorphisms of drug oxidation in man. In: Microsomes and Drug Oxidation. Proceedings of 6th International Symposium on Microsomes and Drug Oxidation. Taylor & Francis, London, pp 349–360
Sugahara K, Schwartz N (1979) Defect in 3’-phosphoadenosine 5’-phosphosulphate formation in brachymorphic mice. Proc Natl Acad Sci USA 76: 6615–6618
Tannen RH, Weber WW (1979) Rodent models of the human isoniazid-acetylator polymorphism. Drug Metab Disp 7: 274–279
Wedlund PJ, Asianian WS, McAllister CB, Wilkinson GR, Branch RA (1984) Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphism. Clin Pharmacol Ther 36: 773–780
Weinshilboum RM (1984) Human pharmacogenetics of methyl conjugation. Fed Proc 43: 2303–2307
Woosley RL, Roden DM, Duff HJ, Carey EL, Wood AJJ, Wilkinson GR (1981) Coinheritance of deficient oxidative metabolism of encainide and debrisoquine. Clin Res 29: 501A
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag
About this paper
Cite this paper
Smith, R.L. (1986). Polymorphism in Drug Metabolism — Implications for Drug Toxicity. In: Chambers, C.M., Chambers, P.L., Tuomisto, J. (eds) Toxic Interfaces of Neurones, Smoke and Genes. Archives of Toxicology, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71248-7_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-71248-7_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16589-7
Online ISBN: 978-3-642-71248-7
eBook Packages: Springer Book Archive